Login Register Cart 0

Articles by Disease (Lung Cancer)

Targeting HER Receptors in Cancer

Journal: Current Pharmaceutical Design
Volume: 19
Page: 808-817
Author(s): Alberto Ocana and Atanasio Pandiella

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Current Status and Future Perspectives in the Development of Novel Irreversible Inhibitors for the Treatment of Mutant Non-small Cell Lung Cancer

Journal: Current Pharmaceutical Design
Volume: 19
Page: 818-832
Author(s): Elena Galvani, Roberta Alfieri, Elisa Giovannetti, Andrea Cavazzoni, Silvia La Monica, Maricla Galetti, Claudia Fumarola, Mara Bonelli, Marco Mor, Marcello Tiseo, Godefridus J. Peters, Pier Giorgio Petronini and Andrea Ardizzoni

Detection and Therapeutic Implications of c-Met Mutations in Small Cell Lung Cancer and Neuroendocrine Tumors

Journal: Current Pharmaceutical Design
Volume: 19
Page: 833-840
Author(s): J. Voortman, T. Harada, R.P. Chang, J.K. Killian, M. Suuriniemi, W.I. Smith, P.S. Meltzer, M. Lucchi, Y. Wang and G. Giaccone

Anti-metastatic Treatment in Colorectal Cancer: Targeting Signaling Pathways

Journal: Current Pharmaceutical Design
Volume: 19
Page: 841-863
Author(s): Clara Lemos, Ulrike Sack, Felicitas Schmid, Manisha Juneja and Ulrike Stein

Inhibition of RET Activated Pathways: Novel Strategies for Therapeutic Intervention in Human Cancers

Journal: Current Pharmaceutical Design
Volume: 19
Page: 864-882
Author(s): Libero Santarpia and Giulia Bottai

Modulation of Sensitivity to Antitumor Agents by Targeting the MAPK Survival Pathway

Journal: Current Pharmaceutical Design
Volume: 19
Page: 883-894
Author(s): Giacomo Cossa, Laura Gatti, Giuliana Cassinelli, Cinzia Lanzi, Nadia Zaffaroni and Paola Perego

PI3K Pathway Inhibitors: Better Not Left Alone

Journal: Current Pharmaceutical Design
Volume: 19
Page: 895-906
Author(s): Ben Markman, Jessica J. Tao and Maurizio Scaltriti

The Intriguing Interplay Between Therapies Targeting the Epidermal Growth Factor Receptor, the Hypoxic Microenvironment and Hypoxia-inducible Factors

Journal: Current Pharmaceutical Design
Volume: 19
Page: 907-917
Author(s): An Wouters, Carolien Boeckx, Jan B. Vermorken, Danielle Van den Weyngaert, Marc Peeters and Filip Lardon

Synergistic Antiproliferative and Antiangiogenic Effects of EGFR and mTOR Inhibitors

Journal: Current Pharmaceutical Design
Volume: 19
Page: 918-926
Author(s): L. Porcelli, A.E. Quatrale, P. Mantuano, N. Silvestris, J.F. Rolland, L. Biancolillo, A. Paradiso and A. Azzariti

Molecular Mechanisms and Modulation of Key Pathways Underlying the Synergistic Interaction of Sorafenib with Erlotinib in Non-Small-Cell-Lung Cancer (NSCLC) Cells

Journal: Current Pharmaceutical Design
Volume: 19
Page: 927-939
Author(s): E. Giovannetti, M. Labots, H. Dekker, E. Galvani, J.S.W. Lind, R. Sciarrillo, R. Honeywell, E.F. Smit, H.M. Verheul and G.J. Peters


© 2025 Bentham Science Publishers | Privacy Policy